Millipore Corporation - - BioPharm International

ADVERTISEMENT

Millipore Corporation

BioPharm International
Volume 18, Issue 12

Company Description



Millipore's technologies are used by most of the world's leading biopharmaceutical companies. We deliver more than advanced filtration, purification and QA/QC products. With Millipore, you have access to services that optimize and validate your processes, resources to streamline and enhance your operation, and unmatched know-how from over 50 years experience.



Millipore has offices and subsidiaries around the world. Visit http://www.millipore.com/offices for the location near you.

Major Products
  • Mobius Flexible Manufacturing Solutions Millipore's Mobius flexible bioprocessing solutions can help achieve greater efficiency and productivity. Our suite of modular technologies and services create one complete disposable manufacturing system, offering reduced validation and cleaning efforts, quick turnaround times, minimized contamination and improved operator safety.
  • The innovative pod platform:The innovative Pod platform is a modular disposable NFF filter format that delivers flexibility for clarification and prefiltration applications. The system is available with Millipore's Millistak+ HC media, which combines charged depth media and membrane technologies to enhance filter capacity and retention in one step. Pods are available with 0.1 m2 , 0.5 m2 , and 1 m2 filtration areas that fit into one of two expandable holders. The pilot-scale holder can accommodate from 0.1 to 2 m2 , or up to 5 m2 with an optional accessory kit. The process-scale holder can hold up to 30 m2 .
  • Proven sterile filtration solutions: Millipore's suite of aseptic processing solutions have been utilized in Millipore's flagship Durapore PVDF membrane and ultra fast Millipore Express PES membranes, which are offered in a range of pore sizes, membrane configurations, and filter formats. Available in cartridge, Opticap XL & XLT capsule, OptiScale and Millipak devices there is a size and filter format for every process need and scale. Whether you are preparing culture media, additives, buffers and other aqueous solutions or removing microorganisms and mycoplasma from product, Millipore has an aseptic processing solution to meet your needs.
  • Chromatography solutions: Offering a range of process and validation services and a comprehensive product line, Millipore will work with you on all your biochromatography needs. ProSep vA Ultra chromatography media is for high throughput affinity purification of MAbs and other proteins. QuikScale columns are used with any biochromatography system from small-scale pilot processes through complex development and manufacturing operations. The K-Prime 40 Biochromatography system separates and purifies proteins, vaccines and other bioengineered products atmethods development, pilot separation and large manufacturing.
  • Process monitoring tools: To test for the presence of airborne and liquid microbial contaminants in raw materials, in-process and final products, Millipore's process monitoring tools allow you to verify that your process is functioning within acceptable operating parameters.
  • The Milliflex Rapid Microbiology Detection System is an automated solution for rapid detection, response and resolution of microbial contamination, and improves process control, product yield and timely release of products. Microorganisms can be detected in 1/4 of the time of current methods.
  • Steritest EZ Sterility testing devices simplify all aspects of testing, from handling to traceability, in a closed concept system. When used with the Steritest Equnox pump, the Steritest system delivers unmatched sterility testing capacity.



Visit http://www.millipore.com/bioprocess to learn more about the products and technologies we offer.

MILLIPORE
290 Concord Road Billerica, MA 01821

TELEPHONE
800.MILLIPORE 800.645.5476

FAX
978.715.1393

WEB ADDRESS
http://www.millipore.com/

EMPLOYEES
4,850 worldwide

FOUNDED
1954

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Mylan to Acquire Abbott's Non-US Businesses in $5.3 Billion Stock Deal
July 14, 2014
Shire and AbbVie Discuss Possible Deal
July 14, 2014
Author Guidelines
Source: BioPharm International,
Click here